Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Hamaike Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Hamaike Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hamaike Biotechnology
Manufacturer of biotechnological products intended to advance medical research, agricultural innovation, and environmental sustainability. The company offers expertise in bio-based materials, precision laboratory instruments, microbial fertilizers, marine bioactive extraction, and cell technology, enabling healthcare providers, agricultural enterprises, and research institutions to enhance productivity, improve health outcomes, and foster sustainable development.
- Sector
- Healthcare
- HQ
- Weihai, China
- Founded
- 2022
- Website
- hmcsystem.com/
- Ownership
- Privately Held (backing)
Hamaike Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hamaike Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hamaike Biotechnology in its N-PORT filings yet. We sweep new filings monthly.